Professional Background
- Chairman, President and Chief Executive Officer of Exact Sciences Corporation, a cancer screening and precision oncology diagnostics tests company, from March 2014 to March 2026, when Abbott completed its acquisition of Exact Sciences.
- President and Chief Executive Officer of Exact Sciences from 2009 to 2014.
- President and Chief Executive Officer of Third Wave Technologies, Inc., a molecular diagnostics company, from 2005 to 2008.
- Served on the Board of Directors of Adaptive Biotechnologies Corporation from 2019 to 2023, the Board of Directors of Epizyme, Inc. from 2017 to 2022, the Board of Directors of CM Life Sciences II Inc. in 2021, and the Board of Directors of SomaLogic, Inc. in 2021.
Other Public Company Boards
Align Technology, Inc.
Key Qualifications and Expertise
Through his more than 20 years of executive leadership experience in the healthcare and diagnostics industries, Mr. Conroy brings extensive business and management experience operating a public company in a highly regulated industry, along with deep knowledge in the innovation, development, regulatory approval, and commercialization of healthcare products.